Would you like to participate ask a question join the surfers in our next episode?

S3-E25.6 – Emerging Concepts In NASH: NAFLD Patient Screening, NASH Management

Surfing the NASH Tsunami shares Dr. Marcelo Kugelmas's portion of the Madrigal Pharmaceuticals presentation at NAFLD, which covers NAFLD patient screening and diagnostics along with NASH patient management. After this, he answers questions from Roger Green, who then interviews Dr. Naim Alkhouri on disease prevalence and strategies for bringing patient to be tested.

This conversation is centered on Marcelo Kugelmas’s portion of Madrigal’s disease-focused presentation at the Chronic Liver Disease Foundation’s LiverConnect meeting this past March in Scottsdale, AZ. Marcelo addresses issues of NAFLD patient screening and NASH patient management. Afterwards, he answers questions and reviews key elements of the presentation with Roger Green. Finally, Roger interviews Dr. Naim Alkhouri on the patient prevalence implications of the San Antonio Military Medical Study (2021), of which he was an author, and on the strategies he uses to bring patients into his practice to be screened (think “Free FibroScan” for the curious.)

This episode and all its conversations are sponsored by Madrigal Pharmaceuticals. Conversations 25.5 and 25.6 are a two-part summary of Madrigal’s disease-focused presentation at the recent CLDF LiverConnect meeting

Request Transcript of This Episode
Request Transcript

NASH & Diabetes Podcast and NASH Tsunami Podcast